Cargando…
Unravelling mitochondrial pathways to Parkinson's disease
Mitochondria are essential for cellular function due to their role in ATP production, calcium homeostasis and apoptotic signalling. Neurons are heavily reliant on mitochondrial integrity for their complex signalling, plasticity and excitability properties, and to ensure cell survival over decades. T...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976614/ https://www.ncbi.nlm.nih.gov/pubmed/24117181 http://dx.doi.org/10.1111/bph.12433 |
_version_ | 1782310310911148032 |
---|---|
author | Celardo, I Martins, L M Gandhi, S |
author_facet | Celardo, I Martins, L M Gandhi, S |
author_sort | Celardo, I |
collection | PubMed |
description | Mitochondria are essential for cellular function due to their role in ATP production, calcium homeostasis and apoptotic signalling. Neurons are heavily reliant on mitochondrial integrity for their complex signalling, plasticity and excitability properties, and to ensure cell survival over decades. The maintenance of a pool of healthy mitochondria that can meet the bioenergetic demands of a neuron, is therefore of critical importance; this is achieved by maintaining a careful balance between mitochondrial biogenesis, mitochondrial trafficking, mitochondrial dynamics and mitophagy. The molecular mechanisms that underlie these processes are gradually being elucidated. It is widely recognized that mitochondrial dysfunction occurs in many neurodegenerative diseases, including Parkinson's disease. Mitochondrial dysfunction in the form of reduced bioenergetic capacity, increased oxidative stress and reduced resistance to stress, is observed in several Parkinson's disease models. However, identification of the recessive genes implicated in Parkinson's disease has revealed a common pathway involving mitochondrial dynamics, transport, turnover and mitophagy. This body of work has led to the hypothesis that the homeostatic mechanisms that ensure a healthy mitochondrial pool are key to neuronal function and integrity. In this paradigm, impaired mitochondrial dynamics and clearance result in the accumulation of damaged and dysfunctional mitochondria, which may directly induce neuronal dysfunction and death. In this review, we consider the mechanisms by which mitochondrial dysfunction may lead to neurodegeneration. In particular, we focus on the mechanisms that underlie mitochondrial homeostasis, and discuss their importance in neuronal integrity and neurodegeneration in Parkinson's disease. LINKED ARTICLES: This article is part of a themed issue on Mitochondrial Pharmacology: Energy, Injury & Beyond. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2014.171.issue-8 |
format | Online Article Text |
id | pubmed-3976614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-39766142015-01-21 Unravelling mitochondrial pathways to Parkinson's disease Celardo, I Martins, L M Gandhi, S Br J Pharmacol Themed Issue: Mitochondrial Pharmacology: Energy, Injury & Beyond Mitochondria are essential for cellular function due to their role in ATP production, calcium homeostasis and apoptotic signalling. Neurons are heavily reliant on mitochondrial integrity for their complex signalling, plasticity and excitability properties, and to ensure cell survival over decades. The maintenance of a pool of healthy mitochondria that can meet the bioenergetic demands of a neuron, is therefore of critical importance; this is achieved by maintaining a careful balance between mitochondrial biogenesis, mitochondrial trafficking, mitochondrial dynamics and mitophagy. The molecular mechanisms that underlie these processes are gradually being elucidated. It is widely recognized that mitochondrial dysfunction occurs in many neurodegenerative diseases, including Parkinson's disease. Mitochondrial dysfunction in the form of reduced bioenergetic capacity, increased oxidative stress and reduced resistance to stress, is observed in several Parkinson's disease models. However, identification of the recessive genes implicated in Parkinson's disease has revealed a common pathway involving mitochondrial dynamics, transport, turnover and mitophagy. This body of work has led to the hypothesis that the homeostatic mechanisms that ensure a healthy mitochondrial pool are key to neuronal function and integrity. In this paradigm, impaired mitochondrial dynamics and clearance result in the accumulation of damaged and dysfunctional mitochondria, which may directly induce neuronal dysfunction and death. In this review, we consider the mechanisms by which mitochondrial dysfunction may lead to neurodegeneration. In particular, we focus on the mechanisms that underlie mitochondrial homeostasis, and discuss their importance in neuronal integrity and neurodegeneration in Parkinson's disease. LINKED ARTICLES: This article is part of a themed issue on Mitochondrial Pharmacology: Energy, Injury & Beyond. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2014.171.issue-8 Blackwell Publishing Ltd 2014-04 2014-03-28 /pmc/articles/PMC3976614/ /pubmed/24117181 http://dx.doi.org/10.1111/bph.12433 Text en © 2013 The British Pharmacological Society |
spellingShingle | Themed Issue: Mitochondrial Pharmacology: Energy, Injury & Beyond Celardo, I Martins, L M Gandhi, S Unravelling mitochondrial pathways to Parkinson's disease |
title | Unravelling mitochondrial pathways to Parkinson's disease |
title_full | Unravelling mitochondrial pathways to Parkinson's disease |
title_fullStr | Unravelling mitochondrial pathways to Parkinson's disease |
title_full_unstemmed | Unravelling mitochondrial pathways to Parkinson's disease |
title_short | Unravelling mitochondrial pathways to Parkinson's disease |
title_sort | unravelling mitochondrial pathways to parkinson's disease |
topic | Themed Issue: Mitochondrial Pharmacology: Energy, Injury & Beyond |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976614/ https://www.ncbi.nlm.nih.gov/pubmed/24117181 http://dx.doi.org/10.1111/bph.12433 |
work_keys_str_mv | AT celardoi unravellingmitochondrialpathwaystoparkinsonsdisease AT martinslm unravellingmitochondrialpathwaystoparkinsonsdisease AT gandhis unravellingmitochondrialpathwaystoparkinsonsdisease |